| 000 | 00898 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513130015.0 | ||
| 264 | 0 | _c19971114 | |
| 008 | 199711s 0 0 heb d | ||
| 022 | _a0017-7768 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLotem, M | |
| 245 | 0 | 0 |
_a[Active specific immunotherapy of malignant melanoma]. _h[electronic resource] |
| 260 |
_bHarefuah _cAug 1997 |
||
| 300 |
_a122-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAntigens, Neoplasm |
| 650 | 0 | 4 | _aCancer Vaccines |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Active |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aMelanoma-Specific Antigens |
| 650 | 0 | 4 |
_aNeoplasm Proteins _ximmunology |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 700 | 1 | _aShiloni, E | |
| 700 | 1 | _aIngber, A | |
| 700 | 1 | _aPeretz, T | |
| 773 | 0 |
_tHarefuah _gvol. 133 _gno. 3-4 _gp. 122-6 |
|
| 999 |
_c9304785 _d9304785 |
||